- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06777498
The Precision Nutrition New York Study (PNNY)
Optimizing Dietary Fiber Eating Patterns to Prevent Obesity and Resulting Metabolic Disorders
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Angela Poole
- Phone Number: 607-255-8796
- Email: pnnystudy@cornell.edu
Study Contact Backup
- Name: Colette Strathman
Study Locations
-
-
New York
-
Ithaca, New York, United States, 14850
- Recruiting
- Cornell University
-
Contact:
- Angela Poole, PhD
- Phone Number: 607-255-8796
- Email: pnnystudy@cornell.edu
-
Principal Investigator:
- Angela Poole, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age is between 21-50 years
- BMI is between 25-30. You can check your BMI here: https://www.cdc.gov/bmi/adult-calculator/index.html
- Must be able to have height, weight, waist, and hip circumference, and body composition measured during the study
- Must be able to provide saliva samples.
- Must be able to provide a phone number and email address at which the study investigators can contact for study-related matters.
- Must be able to increase dietary fiber intake to the recommended level following the instructions on the USDA MyPlate website: https://www.myplate.gov/myplate-plan
- Must be able to provide food records of everything consumed (food, beverage, and supplements) on one weekday and one weekend day (example Tuesday, Saturday) every week during the study. This will be done using an online survey.
- Must be able to provide 10 stool samples over 11 weeks of the study duration. 18) Must have stable weight (within ±3% of usual body weight) for the last two months.
- Must be able to to take an online survey to assess recent dietary fiber intake to determine eligibility.
Exclusion Criteria:
- Electronic medical implant, for example, a pacemaker.
- An existing, UNTREATED, thyroid condition.
- Use of systemic antibiotics (intravenous injection, intramuscular, or oral) within the last 4 months.
- An acute disease at the time of enrollment (Acute disease is defined as the presence of a moderate or severe illness with or without fever).
- A chronic, clinically significant (unresolved, requiring ongoing medical management or medication) pulmonary, cardiovascular, gastrointestinal, hepatic, or renal functional abnormality.
- Any suspected state of immunosuppression or immunodeficiency including HIV.
A history of active UNTREATED gastrointestinal disorders or diseases including
- Inflammatory bowel disease (IBD)
- Ulcerative colitis (mild-moderate-severe)
- Crohn's or celiac disease
- Indeterminate colitis
- Irritable bowel syndrome (IBS) (moderate-severe)
- Persistent, infectious gastroenteritis, colitis or gastritis
- Persistent or chronic diarrhea of unknown etiology
- Clostridium difficile infection (recurrent)
- Chronic constipation
- Previously had bariatric surgery.
- An unstable dietary history as defined by major changes in diet during the previous month. For example, elimination or significantly increased intake of a major food group in the diet.
- Recent history of chronic alcohol consumption defined as more than 5 drinks (or servings) of alcohol per day.
- Female participants: pregnant/lactating.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: Group A: Whole grains then fruits and vegetables
Whole grain intervention then fruits and vegetables
|
TREATMENT 1: Participants will eat whole grains that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when they eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. TREATMENT 2: Participants will eat fruits and vegetables that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when participants eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. |
|
Experimental: Experimental: Group B: Fruits and vegetables then whole grains
Fruits and vegetables intervention then whole grains
|
TREATMENT 1: Participants will eat fruits and vegetables that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when participants eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. TREATMENT 2: Participants will eat whole grains that add up to the required daily fiber needs. Investigators will provide participants with these products. Participants will follow this intervention for a set period of time. The beginning of the intervention will include a ramp up phase when they eat half of the daily fiber needs to prevent any gastrointestinal distress from suddenly consuming a higher fiber diet than usual. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body weight changes
Time Frame: 3-4 weeks
|
For each intervention (whole grains & fruits and vegetables), investigators will measure change in body weight in kg = Post-intervention minus Pre-intervention
|
3-4 weeks
|
|
Body fat percentage changes
Time Frame: 3-4 weeks
|
For each intervention (whole grains & fruits and vegetables), investigators will measure change in fat percentage = Post-intervention minus Pre-intervention
|
3-4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gut microbiome measured by 16S rRNA gene sequencing
Time Frame: 3-4 weeks
|
For each intervention (whole grains & fruits and vegetables), investigators will calculate changes in relative abundance (proportion) of each gut bacterium from Pre-intervention to Post-intervention.
|
3-4 weeks
|
|
Fecal short-chain fatty acid concentrations (SCFAs)
Time Frame: 3-4 weeks
|
For each intervention (whole grains & fruits and vegetables), investigators will measure change in SCFA concentrations = Post-intervention minus Pre-intervention.
We will report the SCFAs acetate, butyrate, and propionate.
|
3-4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB0147806
- 7005865 (Other Grant/Funding Number: USDA NIFA Hatch)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Weight Changes
-
Pusan National University HospitalCompletedWeight Change, Body
-
Texas Tech UniversityEHP LabsCompletedBody Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic ChangesUnited States
-
Washington University School of MedicineCompleted
-
Washington University School of MedicineCompletedWeight ChangeUnited States
-
Chiang Mai UniversityCompleted
-
Hacettepe UniversityCompleted
-
University Hospital Center of MartiniqueRecruiting
-
Huashan HospitalNot yet recruitingWeight Change, BodyChina
-
University of PittsburghTerminatedWeight Loss | Motor ActivityUnited States
-
Peyman SarsangiCompletedLipid Profile | Weight Change | Blood SugarIran, Islamic Republic of
Clinical Trials on Whole Grain Intervention then fruits and vegetables
-
United Arab Emirates UniversityUnknownVisceral ObesityUnited Arab Emirates
-
University of Nebraska LincolnCompletedObesity | OverweightUnited States
-
Texas Tech University Health Sciences CenterCompletedHealth BehaviorUnited States
-
Baylor Research InstituteCompletedCardiovascular Diseases | Hypertension | Chronic Kidney DiseasesUnited States
-
Amsterdam University Medical Centers (UMC), Location...RecruitingObesity Prevention | Microbiome AnalysisNetherlands
-
The University of Tennessee, KnoxvilleActive, not recruitingObesityUnited States
-
University of TorontoUnity Health Toronto; Cancer Care OntarioCompletedHypertension | Diabetes | Heart DiseaseCanada
-
Laval UniversityCompleted
-
Baylor Research InstituteCompleted
-
Laval UniversityCanadian Institutes of Health Research (CIHR)Not yet recruiting